On September 17, members of the Endocrine Society joined over 400 advocates to call on the Congress to provide increased funding for biomedical research as part of the 8th Annual Rally for Medical Research. Although the COVID-19 pandemic prevented participants from gathering in-person, Rally organizers were able to arrange tele- and videoconference meetings for research...
On June 11, the National Institutes of Health (NIH) announced the appointment of Rick Woychik, PhD, as director of the National Institute of Environmental Health Sciences (NIEHS) and National Toxicology Program (NTP). Woychik has been serving as the Acting Director of NIEHS since October 2019 following the retirement of the previous Director, Linda Birnbaum, PhD....
With the severe disruption to research activity due to the COVID-19 pandemic causing strain at labs across the country, the National Institutes of Health (NIH) has had to quickly address the situation for the workforce while also mobilizing to support research activities related to the virus and comorbidities. Despite the extreme challenge of the situation,...
As the pandemic took hold in the U.S. and communities implemented strict social distancing measures, including stay-at-home orders, the Endocrine Society pivoted its advocacy approach to Congress and launched a strategic “virtual” Hill Day to advocate our recommendations for relief legislation. Originally, the Society had planned a Hill Day for April 20 to bring members...
On March 10, a small but mighty group of Endocrine Society members came to Washington D.C., to meet with their congressional delegations. Despite a number of other priorities requiring the attention of Congress, the federal appropriations process for FY 2021 must move forward and this is the time to influence decisions about funding. We used...
A novel way to reach even more patients, clinicians, and researchers is to take your endocrinology skill into the business world. Here we highlight an ENDO 2020 session that will show attendees how industry could be a viable route for researchers and physicians alike. Last year, at ENDO 2019 in New Orleans, three entrepreneurs at...
On December 3-4, following the 2019 European Union (EU) elections and with the installment of the new European Commission, the Endocrine Society brought members from seven EU Member States to Brussels to meet with policy makers and urge them to take action on endocrine-disrupting chemicals (EDCs). A full day of meetings began with a briefing...
Before Congress adjourned for the holidays, the House of Representatives was able to advance legislation that reflected some Endocrine Society priorities related to EDCs. On December 3, Rep. Frank Pallone (D-NJ) introduced the Cosmetic Safety Enhancement Act (HR 5279), which would give the U.S. Food and Drug Administration (FDA) additional authority to regulate harmful chemicals...
On September 17, members of the Endocrine Society joined over 400 advocates to call on the Congress to provide increased funding for biomedical research as part of the 8th Annual Rally for Medical Research. Although the COVID-19 pandemic prevented participants from gathering in-person, Rally organizers were able to arrange tele- and videoconference meetings for research...
